Karex Berhad (5247.KL)
Port Klang, MY
Established in 1988 and headquartered in Port Klang, Malaysia, Karex Berhad operates as an investment holding company primarily focused on the manufacturing and distribution of condoms. The company offers a comprehensive range of products, including personal lubricants, medical probe covers, and Foley balloon catheters utilized for transurethral urinary bladder drainage, alongside gloves. Its product portfolio has expanded to also include hand sanitizers and pre-vulcanised latex items, in addition to a wholesale service for various healthcare goods. Karex Berhad maintains a global presence, conducting business across Africa, Asia, the Americas, and Europe, serving a diverse client base that encompasses brand owners, governmental bodies, non-governmental organizations, and individual retail purchasers.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.00% | -3.03% | -16.52% | -17.95% | -36.42% | -31.91% | -39.24% | -23.20% | -17.95% | -79.57% | -33.88% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 1 | 0 |
| Hold | 2 | 0 |
| Sell | 0 | -1 |
| Strong Sell | 0 | 0 |
-
Revenue growth Household & Personal Products: +3.3%-1.9% Q1'26: -22.2% (vs Q1'25)
-
EPS growth Household & Personal Products: +8.8%-99.1% Q1'26: -225.0% (vs Q1'25)
-
FCF margin FCF growth · Household & Personal Products: +44.8%-4.0% Q1'26: +1.1% (vs Q1'25)
-
EBIT margin Household & Personal Products: +9.9%+1.7% Q1'26: -4.3% (vs Q1'25)
-
ROIC Household & Personal Products: +8.2%+0.9% Q1'26: -2.6% (vs Q1'25)
-
Share dilution Household & Personal Products: +0.2%0.0% Q1'26: +0.0% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Household & Personal Products: -0.51×6.20× Q1'26: 23.37× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Jun 2015 actual |
Jun 2016 actual |
Jun 2017 actual |
Jun 2018 actual |
Jun 2019 actual |
Jun 2020 actual |
Jun 2021 actual |
Jun 2022 actual |
Jun 2023 actual |
Jun 2024 actual |
Jun 2025 actual |
Jun 2026 3 Rev. Ana. 3 EPS Ana. |
Jun 2027 3 Rev. Ana. 3 EPS Ana. |
Jun 2028 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
298.09M
est: 298.04M (+0.0%)
|
343.62M
est: 365.38M (-6.0%)
|
361.45M
est: 367.72M (-1.7%)
|
408.01M
est: 407.14M (+0.2%)
|
378.48M
est: 379.77M (-0.3%)
|
395.07M
est: 407.27M (-3.0%)
|
419.82M
est: 431.48M (-2.7%)
|
421.64M
est: 449.54M (-6.2%)
|
532.07M
est: 470.70M (+13.0%)
|
507.85M
est: 512.00M (-0.8%)
|
498.41M
est: 502.25M (-0.8%)
|
514.07M
480.00M – 534.00M
+2.4% YoY
|
583.73M
512.00M – 656.20M
+13.6% YoY
|
677.05M
611.80M – 734.04M
+16.0% YoY
|
| EBITDA |
82.13M
est: 23.79M (+245.3%)
|
89.17M
est: 29.16M (+205.8%)
|
49.78M
est: 29.35M (+69.6%)
|
29.54M
est: 32.49M (-9.1%)
|
20.88M
est: 30.31M (-31.1%)
|
28.51M
est: 32.50M (-12.3%)
|
25.13M
est: 34.43M (-27.0%)
|
20.88M
est: 35.88M (-41.8%)
|
49.36M
est: 37.57M (+31.4%)
|
65.33M
est: 40.86M (+59.9%)
|
34.02M
est: 40.08M (-15.1%)
|
41.03M
38.31M – 42.62M
+2.4% YoY
|
46.59M
40.86M – 52.37M
+13.6% YoY
|
54.03M
48.83M – 58.58M
+16.0% YoY
|
| EBIT |
74.46M
est: 8.14M (+814.3%)
|
80.00M
est: 9.98M (+701.3%)
|
38.24M
est: 10.05M (+280.6%)
|
15.53M
est: 11.13M (+39.6%)
|
5.23M
est: 10.38M (-49.6%)
|
7.68M
est: 11.13M (-31.0%)
|
2.13M
est: 11.79M (-81.9%)
|
-2.55M
est: 12.28M (-120.8%)
|
22.56M
est: 12.86M (+75.4%)
|
39.83M
est: 13.99M (+184.7%)
|
8.37M
est: 13.72M (-39.0%)
|
14.05M
13.12M – 14.59M
+2.4% YoY
|
15.95M
13.99M – 17.93M
+13.6% YoY
|
18.50M
16.72M – 20.06M
+16.0% YoY
|
| Net Income |
59.55M
est: 61.26M (-2.8%)
|
66.69M
est: 75.41M (-11.6%)
|
27.95M
est: 33.55M (-16.7%)
|
10.10M
est: 12.85M (-21.4%)
|
2.53M
est: 3.27M (-22.5%)
|
228.0K
est: 933.0K (-75.6%)
|
-1.02M
est: 6.45M (-115.8%)
|
-6.19M
est: -3.48M (-78.0%)
|
10.48M
est: 14.74M (-28.9%)
|
23.44M
est: 25.27M (-7.2%)
|
208.0K
est: 17.90M (-98.8%)
|
7.02M
7.02M – 7.02M
-60.8% YoY
|
26.33M
21.06M – 33.70M
+275.0% YoY
|
43.17M
37.76M – 47.90M
+64.0% YoY
|
| SGA |
36.53M
est: 71.72M (-49.1%)
|
53.05M
est: 87.92M (-39.7%)
|
73.66M
est: 88.48M (-16.8%)
|
90.98M
est: 97.97M (-7.1%)
|
85.91M
est: 91.38M (-6.0%)
|
84.17M
est: 98.00M (-14.1%)
|
98.13M
est: 103.83M (-5.5%)
|
96.11M
est: 108.17M (-11.1%)
|
118.27M
est: 113.26M (+4.4%)
|
126.86M
est: 123.20M (+3.0%)
|
134.25M
est: 120.85M (+11.1%)
|
123.70M
115.50M – 128.49M
+2.4% YoY
|
140.46M
123.20M – 157.90M
+13.6% YoY
|
162.92M
147.22M – 176.63M
+16.0% YoY
|
| EPS |
0.06
est: 0.06 (+9.0%)
|
0.07
est: 0.07 (-7.1%)
|
0.03
est: 0.03 (-12.4%)
|
0.01
est: 0.01 (-17.3%)
|
0.00
est: 0.00 (-19.4%)
|
0.00
est: 0.00 (-77.4%)
|
0.00
est: 0.01 (-116.3%)
|
-0.01
est: 0.00 (-78.6%)
|
0.01
est: 0.01 (-29.3%)
|
0.02
est: 0.02 (-7.1%)
|
0.00
est: 0.02 (-98.8%)
|
0.01
0.01 – 0.01
-60.8% YoY
|
0.03
0.02 – 0.03
+275.0% YoY
|
0.04
0.04 – 0.05
+64.0% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-25 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-22 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-21 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-20 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-19 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-18 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-15 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-14 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-13 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-12 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-11 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-08 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-07 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-06 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-05 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-04 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-30 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-29 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-28 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-27 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-24 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-23 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-22 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-21 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-20 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-17 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-16 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Leng Kian Goh | Exec Director of Technical, R&D and Non-Independent Non-Executive Director | 3.0K | male |
| Miah Kiat Goh | Chief Executive Officer & Executive Director | 3.0K | male |
| Ai Ning Tan | Company Secretary | — | — |
| Siew Hong Tan | Company Secretary | — | — |
| Your Can Wong | Chief Strategy & Financial Officer | — | male |
| Madam Yit Chan Tai | Company Secretary | — | — |
| Lai Peng Lim | Chief Innovation Officer | — | female |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 5247.KL
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
